Hironic Co

Hironic Co EPS

The Earnings per Share (EPS) of Hironic Co (149980.KQ) as of Nov 4, 2026 is 251.39 KRW. In the previous year, Earnings per Share (EPS) was -560.68 KRW — a change of -144.84% (higher).

EPS

251.39KRW

YoY

-144.84%

Last updated:

Earnings per Share (EPS) of Hironic Co is 2025 251.39 KRW. Earnings per Share (EPS) of Hironic Co was 2024 -560.68 KRW. It decreases by -144.84% higher compared to the previous year.

The Hironic Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
231.09 KRW
Jan 1, 2020
252.78 KRW
Jan 1, 2021
539.07 KRW
Jan 1, 2022
233.39 KRW
Jan 1, 2023
654.26 KRW
Jan 1, 2024
-560.68 KRW
Jan 1, 2025
251.39 KRW
Jan 1, 2026 (e)
1,790.73 KRW
The Hironic Co EPS history
YEAREPSYoY
est1,790.73KRW+612.34%
251.39KRW-144.84%
-560.68KRW-185.70%
654.26KRW+180.33%
233.39KRW-56.70%
539.07KRW+113.26%
252.78KRW+9.39%
231.09KRW-1,217.35%
-20.68KRW-135.03%
59.04KRW+3.26%
57.17KRW-74.63%
225.35KRW-56.06%
512.88KRW+65.66%
309.60KRW+17.23%
264.10KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hironic Co Stock analysis

What does Hironic Co do? Hironic Co., Ltd. generates revenue through the manufacture and sale of medical equipment for skin and obesity care. The company's product lineup includes MIXEL, designed for treating skin lesions and melasma while enhancing skin texture and tone; MIPL, which addresses pigmentation, wrinkles, vascular issues, acne, and hair removal; MIDEPI, a dedicated hair removal device; DOUBLO, used for skin tightening, rejuvenation, and non-invasive facial and eyebrow lifting; MICOOL, for natural fat cell destruction; and New Midas, targeting body contouring and facial lifting. These products are sold to medical facilities and clinics specializing in dermatology and cosmetic treatments, with a focus on skin and obesity care segments. The company's revenue streams are derived from direct sales of its branded medical devices to healthcare providers. MIXEL and MIPL cater to dermatological treatments, while MIDEPI and MICOOL serve aesthetic and body contouring markets. DOUBLO and New Midas are positioned for non-invasive cosmetic procedures, appealing to clinics seeking advanced solutions for skin tightening and facial rejuvenation. Hironic's product portfolio targets both skin treatment and obesity care, aligning with the growing demand for specialized medical equipment in these sectors. Hironic Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hironic Co stock

Earnings per Share (EPS) of Hironic Co is 251.39 KRW in 2025.

Earnings per Share (EPS) of Hironic Co changed from -560.68 KRW to 251.39 KRW, representing a -144.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Hironic Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hironic Co

All Key Metrics — Hironic Co